Nordic Bone
ABOUT USINVESTORSPIPELINENEWSCONTACTACCOUNTSDIVIDENDEGM & AGM NOTICE

EMA press release 10 January 2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended that Protelos/Osseor should no longer be used to treat osteoporosis.

See the press release here:

http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/01/news_detail_002005.jsp&mid=WC0b01ac058004d5c1

Information about the impact of the recommendation on Osteologix' cooperation with Servier will be posted on Osteologix' website once clarified.

The board of directors